| Elizabeth Nicole Porter, | |
|
137 Eden School Rd, Morgantown, KY 42261-8150 | |
| (270) 991-6152 | |
| Not Available |
| Full Name | Elizabeth Nicole Porter |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 137 Eden School Rd, Morgantown, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053841031 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 162968 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Nicole Porter, 137 Eden School Rd, Morgantown, KY 42261-8150 Ph: () - | Elizabeth Nicole Porter, 137 Eden School Rd, Morgantown, KY 42261-8150 Ph: (270) 991-6152 |
News Archive
Liquidia Technologies today announced a collaboration with the PATH Malaria Vaccine Initiative (MVI) to explore the use of the company's PRINT® particle technology to design next generation malaria vaccines. PRINT technology offers unprecedented control of particle size, shape and chemistry in a highly consistent and scalable manufacturing process, and will be used to deliver a protein in combination with immune stimulating molecules.
Testing for COVID-19 has been central in the fight against SARS-CoV-2/ COVID-19. While most efforts, including regulations, have focused on testing as a clinical medical diagnostic tool, the most powerful forms of testing to help control the pandemic have rarely been used or recognized, according to Michael Mina, MD, PhD.
Weill Cornell Medical College has been awarded three new research grants from the Leukemia & Lymphoma Society totaling $1.8 million. The funds will support critically-needed translational research for blood cancers, accelerating promising discoveries from the laboratory to the patient's bedside.
New research strongly suggests that a mix of preventative agents, such as those found in concentrated black raspberries, may more effectively inhibit cancer development than single agents aimed at shutting down a particular gene.
A 12-week dose of an investigational three-drug hepatitis C combination cleared the virus in 93 percent of patients with liver cirrhosis who hadn't previously been treated, according to a study in the May 5, 2015, issue of The Journal of the American Medical Association.
› Verified 7 days ago
Miss Tori Leighann Cardwell, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 325 N Ashalan Dr, Morgantown, KY 42261 Phone: 270-991-8849 | |
Sierra Byrd, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 S Warren St, Morgantown, KY 42261 Phone: 270-526-3368 | |
Mrs. Tamara R Lynch, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Sha Ro Ley Ln, Morgantown, KY 42261 Phone: 270-999-0169 |